Targeted Protein Degradation Approaches
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Macromolecular Chemistry".
Deadline for manuscript submissions: closed (31 December 2022)
Special Issue Editors
Interests: organic chemistry; chemical characterization
Special Issues, Collections and Topics in MDPI journals
Interests: testicular cancer; infertility; Alzheimer’s disease; cancer therapeutic; neurotoxicity; brain cancer; nanoparticle research; radiation research; bioinformatics; cell and structural biology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Typical medicinal chemistry approaches use potent inhibitors to inhibit protein of interest (POI). However, the continuous use of such inhibitors is compulsory to maintain sustained POI inhibition, with a high pico-to-micromolar inhibitory range, making them susceptible to resistance and on-target/off-target toxicity. On the other hand, inhibitors based on occupancy-driven pharmacology directly degrade the protein of interest, called "protein degraders," and therefore do not necessarily require nanomolar range affinity and continuous targeting of POI. In recent years, there has been success in protein degradation-based strategies. This Special Issue will give an overview of the most recent advances in the field of protein degradation and their applications. In addition, this Special Issue aims to provide selected contributions on applications, strategies, and method development regarding protein degradation.
Topics relevant to consider for this Issue, but limited to:
- Protein Degradation
- Molecular Glues
- Photoresponsive Protein degraders
- PROTACs
- SNIPERs
- LYTICs
- Ubiquitin proteasome system
Dr. Arvind Negi
Dr. Kavindra K. Kesari
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
